SCHEMBL186318

SCHEMBL186318

N[C@]1(OC(=O)NCc2ncc(Nc3ccc(Cl)cc3C(F)(F)F)cc2F)CCOC1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 12/20 0.37
TP53 P04637 2/20 0.35
CYP1A2 P05177 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
CNR1 P21554 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KCNQ3 O43525 1/20 0.32
KCNQ2 O43526 1/20 0.32
KCNE1 P15382 1/20 0.32
KCNQ1 P51787 1/20 0.32
KDM4E B2RXH2 1/20 0.32
P2RX7 Q99572 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL186186 0.93 CNR2 (0.35) CNR2CNR1KCNQ3KCNQ2P2RX7
SCHEMBL186731 0.88 CNR2 (0.35) CNR2P2RX7
SCHEMBL2812273 0.86 CNR2 (0.38) CNR2TP53CYP1A2CYP2D6CYP2C19
SCHEMBL15455029 0.86 CNR2 (0.38) CNR2TP53CYP1A2CYP2D6CYP2C19
SCHEMBL186385 0.84 CYP1A2 (0.38) CNR2TP53CYP1A2CYP2D6CYP2C19
SCHEMBL14865374 0.83 CNR2 (0.39) CNR2TP53CYP1A2CYP2D6CYP2C19
SCHEMBL185877 0.81 P2RX7 (0.36) CNR2P2RX7
SCHEMBL185111 0.80 CNR2 (0.36) CNR2P2RX7
SCHEMBL10065634 0.80 RAB9A (0.39) TP53CYP1A2CYP2D6CYP2C19RAB9A
SCHEMBL2806482 0.79 RAB9A (0.44) CNR2TP53CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed